Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Windyga

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2013
Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia BJ Windyga, T Lissitchkov, O Stasyshyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2012
von Willebrand's disease: a report from a meeting in the Åland islandsE Berntorp, I Peake, U Budde, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studiesE P Mauser-Bunschoten, I Kleine Budde, S Lopaciuk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA studyA Gringeri, C Leissinger, P A Cortesi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2018
Fifth Åland Island conference on von Willebrand diseaseE Berntorp, A Ågren, L Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesA Iorio, A M Barbara, M Makris, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2013
Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia BJ Windyga, T Lissitchkov, O Stasyshyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2012
von Willebrand's disease: a report from a meeting in the Åland islandsE Berntorp, I Peake, U Budde, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studiesE P Mauser-Bunschoten, I Kleine Budde, S Lopaciuk, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA studyA Gringeri, C Leissinger, P A Cortesi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2018
Fifth Åland Island conference on von Willebrand diseaseE Berntorp, A Ågren, L Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2017
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesA Iorio, A M Barbara, M Makris, et al.
Pageof 4